Literature DB >> 17490902

SLC40A1 Q248H allele frequencies and Q248H-associated risk of non-HFE iron overload in persons of sub-Saharan African descent.

James C Barton1, Ronald T Acton, Pauline L Lee, Carol West.   

Abstract

The ferroportin polymorphism SLC40A1 Q248H (exon 6, cDNA 744G-->T; Gln248His) occurs in persons of sub-Saharan African descent with and without iron overload, and is associated with elevated serum ferritin concentrations (SF). However, the risk of iron overload associated with Q248H has not been defined. We tabulated previously reported Q248H allele frequency estimates in African-Americans and Native Africans, and computed the risk of iron overload associated with Q248H in subjects who lacked HFE C282Y. The aggregate Q248H allele frequency in 1038 African-Americans in two cohorts from Alabama and one cohort each from Washington, DC and California was 0.0525 (95% CI: 0.0451, 0.0652); there was no significant difference in frequencies across these cohorts. The aggregate frequency in 259 Natives from southeast Africa in two cohorts was 0.0946 (95% CI: 0.0694, 0.1198); the difference between the frequencies of these cohorts was not significant. The aggregate Q248H frequencies in African-Americans and Native Africans differed significantly (0.0525 vs. 0.0946, respectively; p=0.0021). There were reports of 24 unrelated African-Americans and 15 unrelated Native Africans without HFE C282Y who had iron overload. In African-Americans, the odds ratio (OR) of Q248H-associated risk of iron overload using 610 C282Y-negative control subjects unselected for SF was 1.57 (95% CI: 0.52, 4.72; p=0.29). In Native Africans, the OR using 208 control subjects unselected for SF was 1.05 (95% CI: 0.28, 3.90; p=0.58). We conclude that the frequency of SLC40A1 Q248H is significantly lower in African-Americans than in Native Africans. Although OR estimates of iron overload in African-Americans and Native Africans with Q248H were greater than unity, the increased OR were not statistically significant.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17490902      PMCID: PMC1986732          DOI: 10.1016/j.bcmd.2007.03.008

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  40 in total

1.  Larger genetic differences within africans than between Africans and Eurasians.

Authors:  Ning Yu; Feng-Chi Chen; Satoshi Ota; Lynn B Jorde; Pekka Pamilo; Laszlo Patthy; Michele Ramsay; Trefor Jenkins; Song-Kun Shyue; Wen-Hsiung Li
Journal:  Genetics       Date:  2002-05       Impact factor: 4.562

2.  Ferroportin (Q248H) mutations in African families with dietary iron overload.

Authors:  Lynne McNamara; Victor R Gordeuk; A Patrick MacPhail
Journal:  J Gastroenterol Hepatol       Date:  2005-12       Impact factor: 4.029

3.  The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic.

Authors:  E Beutler; V Felitti; T Gelbart; N Ho
Journal:  Ann Intern Med       Date:  2000-09-05       Impact factor: 25.391

Review 4.  Non-HFE hemochromatosis.

Authors:  Antonello Pietrangelo
Journal:  Semin Liver Dis       Date:  2005-11       Impact factor: 6.115

5.  Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in whites and blacks in the Hemochromatosis and Iron Overload Screening Study.

Authors:  James C Barton; Ronald T Acton; Fitzroy W Dawkins; Paul C Adams; Laura Lovato; Cathie Leiendecker-Foster; Christine E McLaren; David M Reboussin; Mark R Speechley; Victor R Gordeuk; Gordon D McLaren; Phyliss Sholinsky; Emily L Harris
Journal:  Genet Test       Date:  2005

6.  Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3).

Authors:  Vinod Devalia; Kymberley Carter; Ann P Walker; Stephen J Perkins; Mark Worwood; Alison May; James S Dooley
Journal:  Blood       Date:  2002-07-15       Impact factor: 22.113

7.  Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis.

Authors:  Daniel F Wallace; Palle Pedersen; Jeannette L Dixon; Peter Stephenson; Jeffrey W Searle; Lawrie W Powell; V Nathan Subramaniam
Journal:  Blood       Date:  2002-07-15       Impact factor: 22.113

8.  Primary iron overload in African Americans.

Authors:  R K Wurapa; V R Gordeuk; G M Brittenham; A Khiyami; G P Schechter; C Q Edwards
Journal:  Am J Med       Date:  1996-07       Impact factor: 4.965

9.  Inheritance of two HFE mutations in African Americans: cases with hemochromatosis phenotypes and estimates of hemochromatosis phenotype frequency.

Authors:  J C Barton; R T Acton
Journal:  Genet Med       Date:  2001 Jul-Aug       Impact factor: 8.822

10.  Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene.

Authors:  G Montosi; A Donovan; A Totaro; C Garuti; E Pignatti; S Cassanelli; C C Trenor; P Gasparini; N C Andrews; A Pietrangelo
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

View more
  6 in total

Review 1.  Biomarkers of Nutrition for Development (BOND)-Iron Review.

Authors:  Sean Lynch; Christine M Pfeiffer; Michael K Georgieff; Gary Brittenham; Susan Fairweather-Tait; Richard F Hurrell; Harry J McArdle; Daniel J Raiten
Journal:  J Nutr       Date:  2018-06-01       Impact factor: 4.798

2.  A comparison between whites and blacks with severe multi-organ iron overload identified in 16,152 autopsies.

Authors:  James C Barton; Ronald T Acton; Laura E Anderson; C Bruce Alexander
Journal:  Clin Gastroenterol Hepatol       Date:  2009-03-21       Impact factor: 11.382

Review 3.  Reasons why West Africa continues to be a hotbed for hepatocellular carcinoma.

Authors:  Joshua Tognarelli; Nimzing G Ladep; Mary M E Crossey; Edith Okeke; Mary Duguru; Edmund Banwat; Simon D Taylor-Robinson
Journal:  Niger Med J       Date:  2015 Jul-Aug

4.  Analysis of HFE and non-HFE gene mutations in Brazilian patients with hemochromatosis.

Authors:  Paulo Lisboa Bittencourt; Maria Lúcia Carnevale Marin; Cláudia Alves Couto; Eduardo Luiz Rachid Cançado; Flair José Carrilho; Anna Carla Goldberg
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

Review 5.  Diagnosis and Management of Genetic Iron Overload Disorders.

Authors:  William C Palmer; Prakash Vishnu; William Sanchez; Bashar Aqel; Doug Riegert-Johnson; Leigh Ann Kenda Seaman; Andrew W Bowman; Candido E Rivera
Journal:  J Gen Intern Med       Date:  2018-09-17       Impact factor: 6.473

Review 6.  Ferroportin disease: pathogenesis, diagnosis and treatment.

Authors:  Antonello Pietrangelo
Journal:  Haematologica       Date:  2017-11-03       Impact factor: 9.941

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.